Singular Genomics Systems logo

Singular Genomics SystemsNASDAQ: OMIC

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 May 2021

Next earnings report:

18 March 2025

Last dividends:

N/A

Next dividends:

N/A
$54.96 M
-94%vs. 3y high
36%vs. sector
-vs. 3y high
-vs. sector
-84%vs. 3y high
25%vs. sector
-92%vs. 3y high
86%vs. sector

Price

regular market | Thu, 21 Nov 2024 17:44:28 GMT
$21.88+$0.20(+0.92%)

Dividend

No data over the past 3 years
$406.00 K$1.77 M
$406.00 K-$16.80 M

Analysts recommendations

Institutional Ownership

OMIC Latest News

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
globenewswire.com19 September 2024 Sentiment: POSITIVE

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC (“Concentra”) to acquire all of the Company's outstanding shares of common stock for $12.00 per share in cash. As alternative consideration, Concentra stated that it would consider, assuming it receives sufficient interest from existing stockholders, inviting interested stockholders to elect to continue to participate in any future value realized from the Company's ongoing business by receiving a contingent value right in lieu of receiving $12.00 per share in cash.

Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
globenewswire.com12 September 2024 Sentiment: POSITIVE

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received a non-binding proposal from Deerfield Management Company, L.P. and certain affiliated funds (collectively, “Deerfield”), to acquire all of the Company's outstanding shares of common stock that are not already owned by Deerfield for $10.00 per share in cash. Deerfield, an existing stockholder of the Company, indicated in its letter that it intends to invite other major stockholders and existing management to rollover their shares of common stock into the new company.

Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
globenewswire.com30 July 2024 Sentiment: POSITIVE

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the second quarter ended June 30, 2024 after the market close on Tuesday, August 13, 2024. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Singular Genomics Announces 1-for-30 Reverse Stock Split
globenewswire.com21 June 2024 Sentiment: POSITIVE

SAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock. The Company's common stock will begin trading on a split-adjusted basis when the market opens on June 26, 2024 under its current trading symbol “OMIC”. The CUSIP number of the Company's common stock following the reverse stock split will be 82933R 308.

Singular Genomics Systems, Inc. (OMIC) Q1 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: POSITIVE

Singular Genomics Systems, Inc. (NASDAQ: OMIC) will be hosting a conference call to discuss its Q1 2024 results on May 14, 2024, at 4:30 PM ET. Company representatives on the call include Philip Taylor, Drew Spaventa, and Dalen Meeter. The call will be moderated by Matt Sykes, Dan Brennan, and an operator from Goldman Sachs, TD Cowen, and Cowen, respectively. All participants are currently in listen-only mode.

Singular Genomics Systems, Inc. (OMIC) Q3 2023 Earnings Call Transcript
Seeking Alpha14 November 2023 Sentiment: NEUTRAL

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Philip Taylor - IR Drew Spaventa - CEO, Founder & Chairman Dalen Meeter - CFO Conference Call Participants Dan Brennan - TD Cowen Matt Sykes - Goldman Sachs John Sourbeer - UBS Operator Greetings. Welcome to the Singular Genomics Systems, Inc. Third Quarter 2023 Earnings Conference Call.

Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
GlobeNewsWire24 October 2023 Sentiment: NEUTRAL

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the third quarter 2023 after the market close on Tuesday, November 14, 2023. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Singular Genomics Systems, Inc. (OMIC) Q2 2023 Earnings Call Transcript
Seeking Alpha09 August 2023 Sentiment: POSITIVE

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Philip Taylor - IR Drew Spaventa - Founder, Chair and CEO Dalen Meeter - CFO Conference Call Participants Matt Sykes - Goldman Sachs Dan Brennan - TD Cowen Operator Good day, everyone, and welcome to the Singular Genomics Systems, Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation.

Singular Genomics Systems, Inc. (OMIC) Q1 2023 Earnings Call Transcript
Seeking Alpha13 May 2023 Sentiment: POSITIVE

Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Philip Taylor - IR Drew Spaventa - Founder and CEO Dalen Meeter - CFO Conference Call Participants Tom Stevens - TD Cowen John Sourbeer - UBS Michael Ryskin - Bank of America Operator Greetings. Welcome to the Singular Genomics Systems, Incorporated First Quarter 2023 Earnings Conference Call.

Similar Genomics Systems (OMIC) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research09 May 2023 Sentiment: NEUTRAL

Similar Genomics Systems (OMIC) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.31 per share a year ago.

What type of business is Singular Genomics Systems?

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

What sector is Singular Genomics Systems in?

Singular Genomics Systems is in the Healthcare sector

What industry is Singular Genomics Systems in?

Singular Genomics Systems is in the Medical Instruments & Supplies industry

What country is Singular Genomics Systems from?

Singular Genomics Systems is headquartered in United States

When did Singular Genomics Systems go public?

Singular Genomics Systems initial public offering (IPO) was on 27 May 2021

What is Singular Genomics Systems website?

https://www.singulargenomics.com

Is Singular Genomics Systems in the S&P 500?

No, Singular Genomics Systems is not included in the S&P 500 index

Is Singular Genomics Systems in the NASDAQ 100?

No, Singular Genomics Systems is not included in the NASDAQ 100 index

Is Singular Genomics Systems in the Dow Jones?

No, Singular Genomics Systems is not included in the Dow Jones index

When was Singular Genomics Systems the previous earnings report?

No data

When does Singular Genomics Systems earnings report?

The next expected earnings date for Singular Genomics Systems is 18 March 2025